Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

N1280

Sigma-Aldrich

Norclomipramine hydrochloride

≥98% (TLC), powder

Synonym(s):

N-Desmethylclomipramine

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C18H21ClN2 · HCl
CAS Number:
303-48-0
Molecular Weight:
337.29
MDL number:
MFCD00792880
UNSPSC Code:
12352100
PubChem Substance ID:
57654438
NACRES:
NA.22

Quality Level

200

Assay

≥98% (TLC)

form

powder

color

white to yellow

SMILES string

Cl.CNCCCN1c2ccccc2CCc3ccc(Cl)cc13

InChI

1S/C18H21ClN2.ClH/c1-20-11-4-12-21-17-6-3-2-5-14(17)7-8-15-9-10-16(19)13-18(15)21;/h2-3,5-6,9-10,13,20H,4,7-8,11-12H2,1H3;1H

InChI key

KMDDAZOLOSKTKZ-UHFFFAOYSA-N

Biochem/physiol Actions

Tricyclic antidepressant; an active metabolite of clomipramine that preferentially blocks the norepinephrine transporter.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302 + H312 + H332

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

S Härtter et al.
Psychopharmacology, 117(2), 149-153 (1995-01-01)
The selective serotonin reuptake inhibitor fluvoxamine interferes with the metabolism of tricyclic antidepressants. The present investigation was set out to characterize these interactions in vitro using rat liver microsomes and in vivo by analysing levels of clomipramine and metabolites in
K Fujita et al.
European journal of pharmacology, 204(3), 227-233 (1991-11-12)
When rats received a single i.p. injection of clomipramine (20 mg/kg), clomipramine and desmethylclomipramine were rapidly distributed into the brain and their concentrations were markedly higher in the brain than in the serum, while the concentration of the metabolite in
P O Feet et al.
Acta psychiatrica Scandinavica, 89(4), 230-234 (1994-04-01)
A double-blind 12 week trial was undertaken to compare the effects of clomipramine + dixyrazine with clomipramine + placebo in the treatment of panic disorder with or without agoraphobia. Of 45 patients included (21 dixyrazine, 24 placebo), 16 dropped out
Plasma concentrations after a clomipramine intoxication.
L M Stolk et al.
Journal of analytical toxicology, 22(7), 612-613 (1998-12-10)
T Marcourakis et al.
Journal of psychopharmacology (Oxford, England), 13(1), 40-44 (1999-04-30)
Several placebo-controlled trials have shown the efficacy of clomipramine (CMI) in panic disorder. However, none has investigated the relationship between CMI, and desmethylclomipramine (DCMI) plasma levels, and outcome. In this trial, 41 patients meeting the DSM-III-R criteria for panic disorder
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service